TY - CHAP
T1 - Sensory-motor assessment in clinical research trials
AU - Arezzo, Joseph C.
AU - Seto, Shirley
AU - Schaumburg, Herbert H.
PY - 2013
Y1 - 2013
N2 - The assessment of changes in sensory-motor function in clinical research presents a unique set of difficulties. Clinimetrics is the science of measurement as related to the identification of a clinical disorder, the tracing of the progression of the condition under study, and calculation of its impact. The selection of appropriate measures for clinical studies of sensory-motor function must consider validity, sensitivity, specificity, responsiveness, reliability, and feasibility. Reasonable measures of motor function in clinical research include manual examination of muscle strength, electrophysiology, functional scales, patient-reported outcomes (e.g., quality of life), and for severe conditions such as ALS, survival. The assessment of sensory function includes targeted electrophysiology and QOL, as well as more focused measures such as quantitative sensory testing and the scoring of positive symptoms. Each individual measure and each combination of endpoints has its strengths and limitations.
AB - The assessment of changes in sensory-motor function in clinical research presents a unique set of difficulties. Clinimetrics is the science of measurement as related to the identification of a clinical disorder, the tracing of the progression of the condition under study, and calculation of its impact. The selection of appropriate measures for clinical studies of sensory-motor function must consider validity, sensitivity, specificity, responsiveness, reliability, and feasibility. Reasonable measures of motor function in clinical research include manual examination of muscle strength, electrophysiology, functional scales, patient-reported outcomes (e.g., quality of life), and for severe conditions such as ALS, survival. The assessment of sensory function includes targeted electrophysiology and QOL, as well as more focused measures such as quantitative sensory testing and the scoring of positive symptoms. Each individual measure and each combination of endpoints has its strengths and limitations.
UR - http://www.scopus.com/inward/record.url?scp=84881530724&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84881530724&partnerID=8YFLogxK
U2 - 10.1016/B978-0-444-52902-2.00016-3
DO - 10.1016/B978-0-444-52902-2.00016-3
M3 - Chapter
C2 - 23931786
AN - SCOPUS:84881530724
T3 - Handbook of Clinical Neurology
SP - 265
EP - 278
BT - Handbook of Clinical Neurology
PB - Elsevier B.V.
ER -